Leyden Labs
Seedtable Score
56
Startups
2
Funding Rounds
2
Investors
$187.64m
Money raised
Overview
Leyden Labs, based in Amsterdam, specializes in producing medicines to safeguard against respiratory viruses. Their focus on this niche area is significant as current vaccines, masks, and antiviral treatments show limited efficacy against evolving viral threats. By potentially offering broader or more targeted protection, Leyden Labs could become a key player in the biotech and health technology sectors. Backed by major investors like GV and SoftBank Group, the company enjoys strong confidence in its business model and technological innovation. As the focus shifts from reactive to proactive measures, Leyden Labs' products could see substantial demand, solidifying their market position.
- Website: https://leydenlabs.com
- Business model: b2b
- Company size: 11 - 51 employees
- Headquarters: Amsterdam, Netherlands
- Founded: 2020
- Social accounts: Twitter Linkedin
Unlock Complete Company Intelligence
Access comprehensive data and insights available only to Seedtable members
Financial Details
- • Complete funding history and valuations
- • Revenue estimates and financial metrics
- • Investment round details and terms
People & Contacts
- • Complete leadership team profiles
- • Contact information and email addresses
- • Board members and advisors
Market Intelligence
- • Competitive landscape analysis
- • Market position and growth metrics
- • Industry benchmarking data
Premium Tools
- • Export data and generate reports
- • Save companies to custom watchlists
- • API access for data integration
Join 10,000+ Professionals
Trusted by investors, founders, and analysts worldwide
Access detailed insights on 71,000+ companies worldwide
Investors (2)
Funding
Funding series
Funding Series Analysis
The company Leyden Labs has raised a total of $187.64m in funding over 2 rounds.
Key Insights:
- Series B: $140m
- Unknown: $47.64m
Leyden Labs Unknown (2021, $47M)
$47.64m
Leyden Labs Series B (2022, $140M)
$140m